Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5830209 | European Journal of Pharmacology | 2011 | 9 Pages |
Abstract
Flavones have been studied for their activities via benzodiazepine site on the type-A γ-aminobutyric acid (GABAA) receptors, for which knowledge on structure-efficacy relationships has been rather limited in comparison to that on structure-affinity relationships. The present study focused on flavone 6-substitution, implied in previous studies being relevant to efficacy. Structure analogs, each varying only at position 6, were compared, including 6-fluoroflavone, 6-chloroflavone, 6-bromoflavone, and 2â²-hydroxyflavone analyzed in the present study, as well as 6,2â²-dihydroxyflavone reported earlier. Radio-ligand binding assays, whole-cell patch-clamp, and mouse behavioral experiments were performed. In consistent with a previous report, the present whole-cell patch-clamp and animal behavior experiments demonstrated 6-bromoflavone to be a positive modulator at GABAA receptors acting through flumazenil-sensitive high-affinity benzodiazepine site. In contrast, the other two 6-haloflavones were both neutralizing modulators. In vitro electrophysiological and in vivo animal experiments showed that 2â²-hydroxyflavone was a neutralizing modulator, different in efficacy from its structural analog, 6,2â²-dihydroxyflavone, a negative modulator of GABAA receptors. The fact that flavone analogs differing only at position 6 showed drastically different pharmacological properties clearly points to 6-substitution being an important determinant of efficacy. The results suggest that a large width of the first atom on the 6-substituent favors a high binding affinity of the 6-substituted flavone, whereas a large overall volume of the 6-substituent favors positive modulator activity, which could be modified by, e.g., 2â²-hydroxyl substitution. These findings have contributed to the understanding of quantitative structure-efficacy relationships for flavones acting at GABAA receptors, and hence facilitation of flavone-based drug development.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Lihuan Ren, Wing Man Chan, Feng Wang, Zhiwen Xu, Cunyou Zhao, Wai Kin Mat, Yanwen Chai, J. Tze-Fei Wong, Shui Ying Tsang, Hong Xue,